Related Experiment Video
Updated: Sep 18, 2025
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Association between the dietary index for gut microbiota and cardiometabolic multimorbidity: systemic
Sihan Hu1, Jiayuan Song2, Hui Jiang3
1School of Public Health, Guangxi Medical University, Nanning, China.
Objective:
This study targets to investigate the connection between the possibility of Cardiometabolic Multimorbidity (CMM) and the Dietary Index for Gut Microbiota (DI-GM), paying special attention to the mediating roles of systemic inflammatory markers, specifically the Systemic Immune-Inflammation Index (SII) and the Systemic Inflammatory Response Index (SIRI).
Methods:
A cross-sectional study was conducted involving 17,388 eligible participants from the National Health and Nutrition Examination Survey (NHANES) spanning from 2007 to 2020. Weighted logistic regression model was employed to assess the correlation between DI-GM, SII, SIRI, and CMM. Additionally, restricted cubic spline (RCS) regression model was utilized to investigate any potential nonlinear relationships between these variables and the risk of CMM. The degree to which SII and SIRI mediated the link between CMM and DI-GM was assessed using mediation analysis. Additionally, sensitivity and subgroup analyses were conducted to confirm the results.
Results:
A lower risk of CMM was markedly correlated with higher DI-GM scores (OR = 0.94, 95% CI: 0.91-0.98, p = 0.001). An elevated risk of CMM was markedly linked to higher levels of Ln-SII and Ln-SIRI (OR = 1.45, 95% CI: 1.28-1.65, p < 0.001; OR = 1.87, 95% CI: 1.69-2.07, p < 0.001). Higher education levels were associated with a stronger protective effect of DI-GM on CMM, according to subgroup analysis (P for interaction < 0.05). SII and SIRI, which accounted for 8.3 and 18.1% of the total effect, respectively, partially mediated the link between DI-GM and CMM (p < 0.001). Sensitivity analysis proved the stability of the findings.
Conclusion:
According to the study's findings, DI-GM could mitigate the danger of CMM. Reduced systemic inflammation acted as a partial mediating factor in this connection. These findings highlight the mechanisms of gut microbiota to mitigate the danger of CMM from a nutritional perspective. This offers insightful information for clinical CMM therapy and prevention.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...